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Abstract Perinatal asphyxia (PA) is a leading cause of
neuronal damage in newborns, resulting in long-term
neurological and cognitive deficits, in part due to impair-
ment of mesostriatal and mesolimbic neurocircuitries. The
insult can be as severe as to menace the integrity of the
genome, triggering the overactivation of sentinel proteins,
including poly (ADP-ribose) polymerase-1 (PARP-1).
PARP-1 overactivation implies increased energy demands,
worsening the metabolic failure and depleting further
NAD? availability. Using a global PA rat model, we report
here evidence that hypoxia increases PARP-1 activity,
triggering a signalling cascade leading to nuclear translo-
cation of the NF-jB subunit p65, modulating the expres-
sion of IL-1b and TNF-a, pro-inflammatory molecules,
increasing apoptotic-like cell death in mesencephalon of
neonate rats, monitored with Western blots, qPCR, TUNEL
and ELISA. PARP-1 activity increased immediately after
PA, reaching a maximum 1–8 h after the insult, while
activation of the NF-jB signalling pathway was observed
8 h after the insult, with a[twofold increase of p65 nuclear
translocation. IL-1b and TNF-a mRNA levels were
increased 24 h after the insult, together with a [twofold
increase in apoptotic-like cell death. A single dose of the
PARP-1 inhibitor nicotinamide (0.8 mmol/kg, i.p.), 1 h
post delivery, prevented the effect of PA on PARP-1
activity, p65 translocation, pro-inflammatory cytokine
expression and apoptotic-like cell death. The present study
demonstrates that PA leads to PARP-1 overactivation,
T. Neira-Pen˜a  E. Rojas-Mancilla  M. Gutierrez-Hernandez 
M. Herrera-Marschitz






T. Neira-Pen˜a  V. Munoz-Vio  R. Perez 
M. Gutierrez-Hernandez  D. Bustamante  P. Morales 
P. Gebicke-Haerter  M. Herrera-Marschitz (&)
Programme of Molecular & Clinical Pharmacology, ICBM,












T. Neira-Pen˜a  E. Rojas-Mancilla
Universidad Bernardo OHiggins, Santiago, Chile
M. A. Hermoso
Inmunology, ICBM, University of Chile, Santiago, Chile
e-mail: mhermoso@med.uchile.cl
P. Gebicke-Haerter
Department of Psychopharmacology, Central Institute of Mental
Health, J5, Mannheim, Germany
M. Herrera-Marschitz
c/o Goiny; Frihetsva¨gen 29, Ja¨rfa¨lla, 17753 Ja¨rfa¨lla, SE, Sweden
M. Herrera-Marschitz
Av. Independencia, Independencia, Santiago, Chile
123
Neurotox Res (2015) 27:453–465
DOI 10.1007/s12640-015-9517-0
increasing the expression of pro-inflammatory cytokines
and cell death in mesencephalon, effects prevented by
systemic neonatal nicotinamide administration, supporting
the idea that PARP-1 inhibition represents a therapeutic
target against the effects of PA.
Keywords Hypoxia–ischemia  Neonatal rat 
Inflammatory mediators  Basal ganglia  Gene
transcription
Introduction
Obstetric complications are associated to neuropsychiatric
disorders, with hypoxia as a recurrent co-factor, priming
brain development by mechanisms not yet established (see
Low 2004; Basovich 2010).
Delay in starting pulmonary ventilation at birth implies
decrease of oxygen saturation in blood and its supply to the
brain, which depends on aerobic metabolism for maintain-
ing the respiratory chain and mitochondrial ATPase activ-
ity. Whenever hypoxia is sustained, there is a switch to
glycolysis, a poor metabolic alternative, because of low
stores of glucose in brain tissue and deficient ATP output by
the glycolysis pathway, resulting also in lactate accumula-
tion and acidosis. Prolonged hypoxia not only decreases
gene expression and translation, but also increases the
expression of sentinel proteins, such as poly(ADP-ribose)
polymerases (PARPs) (Ame´ et al. 2004; Martin et al. 2005).
Oxidative stress is inherent to re-oxygenation, resulting in
over activation and inactivation of buffering enzymes (see
Gitto et al. 2002). Indeed, in the clinical scenario, resusci-
tation implies hyperoxemia, free radical production and
oxidative stress, worsening brain injury (Davis et al. 2004;
Solberg et al. 2007; Kapadia et al. 2013).
Delayed cell death is an important endpoint of perinatal
asphyxia (PA), associated to caspase-dependent and -
independent mechanisms (Northington et al. 2001).
Regionally selective nuclear fragmentation is observed in
control and asphyxia-exposed rat pups, depending upon the
stage of development and the analysed brain region, but
apoptosis is sustained only in asphyxia-exposed animals
(Dell’Anna et al. 1997).
The regional vulnerability of basal ganglia neurocir-
cuitries to anoxia/ischemia has been pointed out by dif-
ferent groups (Pasternak et al. 1991; Pastuzko 1994;
Cowan et al. 2003; Miller et al. 2005; Ferrari et al. 2011),
reflecting either (i) the severity of the insult; (ii) the local
metabolic imbalance during the re-oxygenation period and/
or (iii) the developmental stage of the affected regions.
Immaturity of a particular brain region plays a role,
because the insult affects neuritogenesis and synaptogen-
esis (see Herrera-Marschitz et al. 2014).
PARP-1 is the most abundant and conserved member of
a large protein superfamily, displaying a conserved cata-
lytic domain for transferring ADP-riboses from NAD? to
glutamic and aspartic residues of the PARPs and their
substrates, catalysing ADP-ribose polymerisation (pADPr).
PARP-1 is involved in DNA repair, but overactivation of
PARP-1 leads to NAD? exhaustion and energy crisis
(Berger 1985), inducing caspase-independent apoptosis
(Jiang et al. 1996; Yu et al. 2002; see Hong et al. 2004).
PARP-1 overactivation can promote nuclear factor jB
(NF-jB) translocation (Hassa and Hottinger 1999) and
expression of pro-inflammatory cytokines (Ullrich et al.
2001; Chiarugi and Moskowitz 2003; Hamby et al. 2007).
We report here that PA induces PARP-1 overactivation,
in tandem with activation of pro-inflammatory signalling,
increasing IL-1b and TNF-a mRNA levels and cell death
in mesencephalon of rat neonates. Thus, PARP-1 overac-
tivation is an early endpoint for PA, providing a target for
preventing the effects elicited by metabolic insults at birth.
As a proof of principle, we investigated the effect of nic-
otinamide (Virag and Szabo 2002) on PARP-1 activity, p65
nuclear translocation, inflammatory signalling and cell
death, evaluated during the 24 h period following birth.
Materials and Methods
Animals
Wistar albino rats from the animal station of the Molecular
& Clinical Pharmacology Programme, ICBM, Faculty of
Medicine, University of Chile, Santiago, Chile, were used
along the experiments. The animals were kept in a tem-
perature- and humidity-controlled environment with a
12/12 h light/dark cycle and fed ad libitum, when not used
for the experiments, monitoring permanently the well being
of the animals by qualified personnel.
Ethic Statement
All procedures were conducted in accordance with the
animal care and use the protocol established by a Local
Ethics Committee for experimentation with laboratory
animals at the Medical Faculty, University of Chile
(Comite de Bioetica Sobre Investigacion en Animals). The
protocol was approved by the Ethics Committee (Protocol
CBA#0447, FMUCH; August 4, 2011), which follows the
Council Directive 2010/63EU of the European Parliament
and the Council of 22 September 2010 on the protection of
animals used for scientific purposes, as well as the
Guidelines laid down by the NIH in USA. The protocol
was further approved by the Comite Asesor de Bioetica,
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CONICYT the main granting institution in Chile (No.
018/FONDECYT/Medicina G1/615; 30 May 2012).
Care and Final Cause of Each Animals
After using all pups, surrogate dams were kept alive for
further programmed mating, delivery and surrogation (for
3–4 cycles), being then discharged according to established
protocol, implying anaesthesia (cloral) and dislocation
supervised by the Central Department of Experimental
Animals of the Medical Faculty of the University of Chile.
Experimental. Control animals were permanently moni-
tored (on 24 h basis) regarding wellbeing, following the
ARRIVE guidelines for reporting animal studies (www.
nc3rs.org.uk/ARRIVE).
Perinatal Asphyxia
Rats within the last day of gestation (G22) were anaes-
thetized, euthanized by neck dislocation and hysterecto-
mised. One or two pups were removed immediately and
used as non-asphyxiated caesarean-delivered controls (CS),
and the uterine horns containing the remaining foetuses
were immersed in a water bath at 37 C for 21 min (AS).
Following asphyxia, the uterine horns were incised and the
pups were removed and stimulated to breathe. A group of
CS (n = 5) and AS (n = 6) rats was euthanized immedi-
ately after delivery (0 h), in order to evaluate the effect of
hypoxia, without any re-oxygenation. Otherwise, CS and
AS were euthanized 1 h (CS n = 13; AS n = 13), 8 h (CS
n = 24; AS n = 22) and 24 h (CS n = 26; AS n = 26)
after delivered. After decapitation, the brain was rapidly
removed and brain tissue was dissected on ice and stored at
-80 C, pending further experiments. Alternatively, the
animals were first fixed with formalin. When required the
pups were nursed by surrogate dams, and closely moni-
tored for proper reception.
Nicotinamide Treatment
One hour after birth, asphyctic and control rats were
treated with a single dose of nicotinamide 0.8 mmol/kg
(Sigma, St. Louis, MO, USA) (100 mg/kg, i.p.) or Saline
(NaCl 0.9 %, i.p.) in a volume of 0.1 mL using a 0.5 mL
insulin syringe (ANam n = 31; ASal n = 32; CNam
n = 30; CSal n = 33). Thereafter, rats were euthanized
and tissue was dissected in order to evaluate (i) PARP-1
activity; (ii) inflammatory-related molecules 2, 8 and 24 h
post PA and (iii) cell death with a TUNEL assay 24 h
post PA.
Protein Extraction
For total protein extraction, pups were euthanized, 0–24 h
post-birth. Mesencephalon and other suitable regions were
dissected, frozen in liquid nitrogen and stored at -80 C.
Tissue was homogenized with a glass–glass homogenizer
in ice-cold RIPA buffer (150 mM NaCl, 1 % Trito´n X-100,
0.1 % SDS, 50 mM Tris pH 8; 0.5 % sodium deoxicolate)
containing a Protease Inhibitor Cocktail Set III, EDTA-
Free (Calbiochem, Darmstadt, Germany) and supple-
mented with 0.5 mM DTT, 0.1 mM Na3VO4, 100 lg/mL
PMSF, 2 lg/mL leupeptin, 2 lg/mL aprotinin and 0.05 %
Triton X-100. The homogenizate was incubated 30 min on
ice, and centrifugated for 30 min at 13,500 rpm at 4 C,
recovering the supernatant.
Nuclear and Cytoplasmatic Protein Extracts
Nuclear and cytoplasmatic proteins were extracted with a
CelLyticTM NUCLEARTM Extraction kit (Sigma, St.
Louis, MO, USA) as described by the manufacturer.
Briefly, tissue was homogenized in lysis buffer containing
0.1 M DTT and a protease inhibitor cocktail. The ho-
mogenizate was centrifugated at 11,0009g for 20 min at
4 C. The supernatant containing cytoplasmatic proteins
was recovered; the pellet resuspended in an extraction
buffer, supplemented with 0.1 M DTT and a protease
inhibitor cocktail. The homogenizate was agitated for
30 min and centrifugated at 21,0009g for 5 min at 4 C,
recovering the supernatant containing nuclear proteins.
Protein Quantification
Protein levels were determined by the bicinchoninic acid
(BCA) method (Pierce, BCATM Protein Assay kit). BCA
reacts with peptide bonds producing a purple end product.
Equal amount (200 lL) of reagent A (1 % sodium BCA;
2 % sodium carbonate; 0.16 % sodium tartrate; 0.4 %
NaOH and 0.95 % sodium bicarbonate) and reagent B
(4 % cupric sulphate in 59 H2O) were mixed with 10 lL
of each sample and incubated at 37 C for 30 min. Samples
were read at 562 nm in a Multi-Mode Microplate Reader
(Biotek Instruments, Inc). A standard curve of absorbance
versus micrograms of BSA protein was prepared, calcu-
lating the protein concentration for each sample.
Western Blots Analysis
25 or 50 lL of protein extracts was mixed with sample
buffer (125 mM Tris–HCl, pH 6.8; 2 % SDS, w/v; 20 %
glycerol, w/v; 20 lg/lL bromophenol blue and 5 % b-
mercaptoethanol), boiled for 5 min, separated by electro-
phoresis on a 8 % SDS-PAGE gel and blotted onto a
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BioTraceTM pure nitrocellulose membrane (Pall Corpora-
tion, Pensacola, FL, USA). Membranes were blocked with
Tris-buffered saline (TBS) containing 0.1 % Tween-20 and
5 % (w/v) non-fat dry milk at room temperature for 1 h,
and incubated with (i) mouse anti-pADPr (170–70 kDa)
(3H2844) (sc-71848, Santa Cruz Biotechnology); (ii) goat
anti-PARP-1 (113 kDa) (sc-F0908, Santa Cruz Biotech-
nology); (iii) Rabbit anti-p65 (65 kDa) (sc-372, Santa Cruz
Biotechnology); (iv) Mouse anti-iKB-a (35–41 kDa) (sc-
1643, Santa Cruz Biotechnology); (v) Mouse anti-b-actin
(42 kDa) (Sigma A5316); (vi) Rabbit anti-histone H4
(13–15 kDa) (Abcam 1261) and (vii) mouse anti-a-tubulin
(45 kDa) (Sigma T8203). Membranes were washed and
incubated with HRP-conjugated secondary antibody in
TBS at room temperature. The immune complexes were
visualized with an enhanced chemiluminescent substrate,
according to the instructions of the manufacturer (Perkin
Elmer Life Sciences, Boston, MA), captured by a Chemi-
Scope 3400 (Clinx Sciences Instruments Co, Ltd). Reactive
bands were quantified by densitometric analysis with
Photoshop software.
Quantitative Real Time PCR (RT-qPCR)
Total RNA was extracted from brain samples using TRIzol
(Invitrogen, USA). RNA was treated with TURBO DNA-
freeTM (Ambion Texas USA) and subsequently verified for
optical density 260/280 absorption ratios. RNA integrity
was evaluated by denaturing gel electrophoresis. CDNA
was synthesized with an ImProm II reverse transcription
system (Promega, Madison, USA), using oligo dT primers.
RT-qPCR was performed using 2X Brilliant III SYBR
Green QPCR Master Mix (Agilent Technologies, USA) in
a MX3000 system (Stratagene, La Jolla, CA, USA). Primer
sequences were designed with Primer3 software as follows:
Data were Analysed in Triplicates with MxPro
Software, and Normalized to GAPDH mRNA Levels
Enzyme-Linked Assay (ELISA)
Quantification of IL-1b and TNF-a protein levels in brain
tissue was performed by ELISA. The tissue was homoge-
nized with a lysis buffer (25 mM Tris buffer, pH 7.4;
150 mM NaCl; 2 mM EDTA) containing a protease
inhibitor cocktail (Calbiochem, Darmstadt, Germany).
Samples were centrifugated at 15,000 g for 15 min at 4 C,
recovering the supernatant. Proteins were quantified as
described above by the BCA method. A solid phase ELISA
was performed using Quantikine ELISA, Rat IL-1b and
Quantikine ELISA Rat TNF-a for measuring the respec-
tive cytokines, as described by the manufacturer. Briefly,
50 lL of standard, control or sample was added into mi-
croplates coated with a monoclonal antibody against IL-1b
or TNF-a, incubated for 2 h at room temperature. Plates
were washed and incubated with 100 lL of rat polyclonal
anti-rat IL-1b or rat polyclonal anti-TNF-a conjugated with
horseradish peroxidase for 2 h at room temperature. The
plates were washed and incubated with 100 lL of the
substrate solution containing hydrogen peroxide (H2O2)
and tetramethylbenzidine as chromogen for 30 min at room
temperature. The reaction was stopped and optical density
was determined using a Multi-Mode Microplate Reader
(Biotek Instruments, Inc) set at 450 nm.
The concentration of cytokines was calculated by
extrapolation from a standard curve. Each sample was run
by duplicated and the pg of cytokines was standardized by
mg of protein for each sample.
Tissue Preparation for Evaluation of Apoptotic-Like Cell
Death (TUNEL ASSAY)
Rat neonates (24 h after birth) were transcardially perfused
with warm phosphate-buffered saline (PBS; 0.1 M; pH 7.4),
followed by 4 % formalin solution in PBS. The brain was
rapidly dissected and post-fixed for 24 h at 4 C in the same
fixative solution, and kept in 30 % sucrose for 48 h. There-
after, the brains were serially cut into 20-lm-thick coronal
cryostat sections. The sections were mounted on gelatinized
slides and stored at -20 C, pending further experiments.
Apoptotic-like DNA fragmentation was assessed with
the TUNEL assay Apop Tag Plus Peroxidase in Situ
Apoptosis Detection kit (Millipore, Temecula, CA).
Coronal sections were washed with PBS, and permeabili-
zed with an ethanol:acetic acid (2:1) solution, quenched
with 3 % H2O2 (v/v) for 5 min followed by 2 x washing
with PBS. The terminal deoxynucleotidyl transferase (TdT)
enzyme was added to the pre-equilibrated tissues and
incubated for 1 h at 37 C. Stop-buffer was added to the
Primers Forward sequence Reverse sequence
p65 50-ATAACTCGC CTGGTGACAGGAT-30 50-CTGAGAAGTCCATGTCCGCAAT-30
IL-1b 50-CTGCAGGCTTCGAGATGAACAA-30 50-TGTCCATTGAGGTGGAGAGCTT-30
TNF-a 50-GGCCAATGGCATGGATCTCAAA-30 50-AGC CTT GTC CCT TGA AGA GAA C-30
GAPDH 50-CCTGCC AAGTATGATGACATCAA-30 50-AGC CCA GGA TGC CCT TTA GT-30
456 Neurotox Res (2015) 27:453–465
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slide and agitated for 15 s and incubated for 10 min at
room temperature. After washing three times with PBS for
1 min each, anti-digoxigenin peroxidase conjugate was
added to the slides and incubated for 30 min. The slides
were washed twice with PBS, and the freshly prepared
peroxidase substrate 3,30-diaminobenzidine was added to
the slides for 7 min at room temperature, and then washed
two times with distilled water. The sections were coun-
terstained with 0.5 % Methyl Green (w/v) for 10 min fol-
lowed by washing with water and then 100 % n-butanol.
After 10 min, sections were dehydrated in xylene for 2 min
and cover-slipped with Entellan (Merck, Darmstad, Ger-
many). The stained sections were examined with a Nikon
TS100 microscope. A preliminary observation under 10X
was necessary for clearly identifying the selected brain
areas. The number of TUNEL positive cells was quantified
in 3–7 subareas (4.5 9 104 lm2) from top to bottom for
each section, from right to left hemisphere. The number of
positive cells was expressed as the average of TUNEL
positive cells per mm3.
Statistical Analysis
All data are expressed as mean ± SEM. The following are
the experimental groups: (i) caesarean-delivered controls
(CS); (ii) caesarean-delivered saline-treated controls
(CSal); (iii) asphyxia-exposed (AS); (iv) asphyxia-exposed
saline-treated (ASal); (v) caesarean-delivered nicotin-
amide controls (CNam) and (vi) asphyxia-exposed nico-
tinamide-treated (ANam) rat pups. Nicotinamide treatment
was compared to the corresponding saline-treated controls,
which is specifically indicated when required (see Mate-
rials and Method section). Pair-wise comparisons were
evaluated with Student’s t-test, followed by Bonferroni
correction to counteract the probability of false-positive
results due to multiple comparisons, using a GraphPad




The experimental model implies a global non-invasive
hypoxic insult occurring at the time when rats normally
deliver (see Herrera-Marschitz et al. 2011). When possible,
an Apgar scale is applied 1 h after delivery, to evaluate the
severity of the insult. Compared to the controls (CS), the
rate of survival was decreased following 21 min of PA
(AS) (by *40%). Surviving AS rats showed several
abnormal parameters, indicating physiological and behav-
ioural impairment, but were properly nursed by surrogate
dams, independently upon nicotinamide or saline
treatment.
PARP-1 Levels: Estimation of Enzymatic Activity
(Fig. 1)
The enzymatic activity of PARP-1 was estimated and
expressed by the ratio of pADPr and PARP-1 (evaluated in
the same membrane after stripping) levels, standardized by
b-actin. PARP-1 activity was evaluated following hypoxia
alone (immediately after delivery, 0 h) or after re-oxy-
genation was established (1–24 h), compared to the
respective control rats.
Figure 1 shows pADPr, PARP-1 levels and PARP-1
activity measured in mesencephalon of CS and AS animals.
In A, representative immunoblots of pADPr (170–70 KDa),
PARP-1 (113 KDa) and b-actin (42 KDa) levels, in CS and
AS animals, immediately (0 min) or 1–24 h after delivery,
are shown. In B, pADPr levels are quantified as arbitrary
units (A.U.), showing that pADPr levels increased after
caesarean delivery, reaching a plateau 8 h after birth (white
columns). In AS animals (grey columns), pADPr levels
were increased, compared to CS animals, reaching a
maximum 1 h after birth. In C, PARP-1 levels are stan-
dardized by b-actin levels, not showing any statistically
significant differences among the groups, apart of a tran-
sient difference between AS versus CS, occurring at 8 h,
when PARP-1 levels were decreased in AS animals. In D,
PARP-1 activity is expressed as the ratio between pADPr
and PARP-1, making evident that PARP-1 activity was
increased in AS animals, 0–8 h after birth. No further
differences were observed at 24 h.
NF-jB Signalling Pathway Following PA and Re-
oxygenation (Fig. 2)
IkBa and p65 levels were measured by Western blots in
both CS and AS animals 1–24 h after delivery. IkBa was
measured in total protein extracts, together with b-actin,
while p65 was measured in cytoplasmic and nuclear
extracts, together with a-tubulin and histone H4, for
demonstrating the purity of the respective protein fractions.
The novo synthesis of mRNA, including p65, IL-1b and
TNF-a, was evaluated with RT-qPCR, 8–24 h after birth.
Figure 2 shows IkBa and p65 levels measured by
Western blots in mesencephalon of CS and AS animals. In
A, representative immunoblots of IkBa (35–41 kDa), and
b-actin (42 kDa) of CS and AS animals, 1–24 h after
delivery, are shown. In B, IkBa normalized to b-actin
(A.U.), showing that IjBa levels were increased in CS, but
not in AS animals 8 h after delivery. IjBa levels were
decreased in AS compared to that observed in CS animals.
Otherwise, IjBa levels were rather stable along the
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experimental conditions, without any further statistically
significant pair-wise differences along the evaluated peri-
ods. In C, representative immunoblots of p65 (65 kDa), a-
tubulin (45 kDa) and histone H4 (15–11 kDa) in cyto-
plasmic (c) and nuclear (n) extracts are shown. In D,
nuclear p65/total p65 in CS and AS animals, 1–24 h after
delivery is shown. While decreased 1 h after delivery,
nuclear p65 translocation increased [ twofold 8 h after
delivery in AS, compared to CS. In E and F, IL-1b and
TNF-a mRNA levels were measured by RT-qPCR, nor-
malized to GAPDH levels, 8 and 24 h after delivery,
showing that both IL-1b and TNF-a mRNA levels were
increased in AS compared to CS animals, 24 h after
delivery.
Apoptotic-Like Cell Death: Effect of Nicotinamide
(Fig. 3)
The number of apoptotic nuclei was measured in sections
from mesencephalon of asphyxia exposed and control
animals with the TUNEL assay 24 h after delivery. Cells
were counted on the stage of a Nikon microscope at 100 X
on consecutive 20 lm sections, expressed as number of
TUNEL-positive cells per mm3. A different series of
asphyxia-exposed and caesarean-delivered control rats was
treated either with a single dose of nicotinamide (0.8 mmol/
kg, i.p.) (ANam, CNam) or with an equivalent amount of
saline (0.1 mL, i.p.) (ASal, CSal), 1 h after delivery.
Figure 3 shows the quantification of apoptotic-like cell
death, evaluated with the TUNEL assay. In A, represen-
tative microphotographs illustrating TUNEL-positive cells
in mesencephalon of CS and AS animals, 24 h after birth.
In B, the number of TUNEL-positive cells was signifi-
cantly increased in AS, compared to CS rats, both in sub-
stantia nigra (SN) and ventral tegmental area (VTA).
Nicotinamide treatment decreased apoptotic-like cells in
mesencephalon of asphyxia-exposed animals (ANam ver-
sus ASal), both in SN and VTA. A decrease of apoptotic-
like cells was also observed in control animals treated with
nicotinamide (CNam versus CSal).
Fig. 1 Effect of perinatal asphyxia on pADPr, PARP-1 levels and
PARP-1 activity in mesencephalon of rat neonates, 0–24 h after
delivery. Caesarean-delivered control (CS) and asphyxia-exposed
(AS) rats were euthanized immediately after delivery (0 h), or
following re-oxygenation (1–24 h), brain tissue sampled and treated
for Western blots. a Representative immunoblots for pADPr
(170–70 kDa), PARP-1 (113 kDa) and b-actin (42 kDa) levels
following hypoxia and/or re-oxygenation. b pADPr levels (expressed
as arbitrary units, A.U.) (CS open columns, AS grey columns).
c PARP-1 levels, normalized to b-actin, A.U.). d PARP-1 activity
(pADPr/PARP-1 ratio) (CS open circles, AS filled triangles). Pair-
wise comparisons were analysed with Student t test (*p \ 0.05,
**p \ 0.005; n = 5–7, for each condition and experiment)
458 Neurotox Res (2015) 27:453–465
123
Effect of Nicotinamide Treatment on PARP-1 Activity
(Fig. 4)
The effect of nicotinamide on PARP-1 activity was eval-
uated at an earlier stage (2 h after birth) than that for
inflammatory proteins (8–24 h) or apoptosis (24 h), to pick
up a sequential effect leading to the endpoint.
Figure 4 shows the effect of nicotinamide (CNam,
ANam), or saline (CSal, ASal) on pADPr (A, B), PARP-1
levels (C) and PARP-1 activity (D) 2 h after birth. Nic-
otinamide decreased pADPr levels (B) and PARP-1
activity (D) (ANam versus ASal). No differences were
observed in PARP-1 levels (C) between any of the
groups.
Effect of Nicotinamide on the Inflammatory Cascade
Elicited by PA (Fig. 5)
Figure 5 shows the effect of nicotinamide on p65 translo-
cation and on p65 mRNA levels in mesencephalon from
control and asphyxia-exposed animals, 8 and 24 h after
birth. In A, representative immunoblots of p65 (65 kDa), a-
tubulin (45 KDa) and histone H4 (15–11 kDa) in cyto-
plasmic (c) and nuclear (n) extracts are shown. In B,
quantification of nuclear p65/total p65 in CSal, CNam, ASal
and ANam animals is shown. Nicotinamide increased p65
translocation in control (CNam versus CSal), but decreased
p65 translocation in asphyxia-induced (ANam versus AS-
aline) animals, 8 h after delivery, but no statistically
Fig. 2 Effect of perinatal asphyxia on IjBa, nuclear translocation of
p65, IL-1b and TNF-a mRNA levels in mesencephalon of rat
neonates, 1–24 h after birth. Caesarean-delivered control (CS) and
asphyxia-exposed (AS) rats were euthanized 1–24 h after delivery,
and brain tissue sampled and treated for Western blots or RT-qPCR.
a Representative immunoblots for IjBa (35–41 kDa) and b-actin
(42 kDa) levels. b IjBa levels (normalized to b-actin; A.U. arbitrary
units) (CS open columns, AS grey columns). c Representative
immunoblots for p65 (65 kDa), a-tubulin (45 kDa) and histone H4
(15–11 kDa) levels, measured in cytoplasmic (c) and nuclear
(n) protein extracts. d Nuclear p65 levels normalized to total p65.
e, f IL-1b (E) and TNF-a f mRNA levels measured by RT-qPCR with
specific primers; analysed in triplicates with MxPro software and
normalized to GAPDH mRNA levels. Pair-wise comparisons ana-
lysed with Student t test (*p \ 0.05, ***p \ 0.0005; n = 5–7, for
each condition and experiment)
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significant level was reached. In C, p65 mRNA/GAPDH
mRNA levels in saline and nicotinamide-treated asphyxia-
exposed and control animals 8–24 h after delivery, and in D
IL-1b mRNA, were evaluated under the same conditions.
No differences were observed among any of the conditions.
As shown in E, TNF-a mRNA levels were, however, sig-
nificantly decreased by nicotinamide, both in control and
asphyxia-exposed animals, 24 h after delivery. When TNF-
a protein levels were measured with ELISA, it was evident
that asphyxia increased TNF-a levels 24 h after delivery,
which was reversed by nicotinamide (Fig. 5F). No effect
was observed on IL-1b protein levels (data not shown).
Discussion
PA implies interruption of oxygen availability, leading to
death if oxygenation is not promptly re-established. In the
present study, ready to birth rat foetuses (removed by
caesarean at G22) were immersed into a water bath for
21 min, resulting, when delivered and stimulated to
breathe, in a significant decrease of the survival rate. As
characterized by an Apgar scale, PA surviving pups
showed several signs of physiological impairment, mainly
affecting cardiovascular and CNS-dependent functions.
When assayed 24 h after birth, it was clear that the insult
led to TUNEL-positive cell death in different brain regions,
mainly in mesencephalon.
Cell death can be a direct result of the shifting from
aerobic to inefficient anaerobic metabolism produced by
asphyxia, generating long-lasting metabolic by-products
and acidosis. Otherwise, cell death can be the consequence
of re-oxygenation, which is a requirement for survival,
leading to hyperoxemia, increasing ROS levels (Mishra
et al. 2003; Strosznajder et al. 2010) and affecting CNS
development, since brain tissue is particularly vulnerable to
Fig. 3 Effect of perinatal asphyxia on apoptotic-like cell death in
mesencephalon of rat neonates, 24 h after delivery: prevention by
systemic nicotinamide treatment. Caesarean-delivered control (CS)
and asphyxia-exposed (AS) rats were anaesthetized and transcardially
perfused with buffered saline and a formalin solution 24 h after
delivery. DNA fragmentation was evaluated in coronal brain
sections (20-lm thick) with the TUNEL assay, counterstained with
methyl green. The number of TUNEL-positive cells per mm3 was
determined in substantia nigra (SN), and ventral tegmental area
(VTA). a Representative microphotographs, from SN of control and
asphyxia-exposed animals; TUNEL-positive cells are brown (arrows)
(bar 10 lm). Inset shows a section from Foster atlas (1998),
indicating the sampling area (white rectangles). b TUNEL-positive
cells were manually counted on the stage of a Nikon TS100
microscope (magnification 9100), expressed as number of TUNEL-
positive cells/mm3 in CS and AS animals, or in parallel animal series
following a single dose of nicotinamide (0.8 mmol/kg, i.p.) (CNam,
ANam) or saline (0.1 ml, i.p.) (CSal, ASal) 1 h after delivery; also
fixed at 24 h (CSal open columns; CNam dashed columns, ASal grey
columns, ANam doubled dashed columns). Pair-wise comparisons
analysed with Student t test (*p \ 0.05; n = 4–5, for each condition)
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ROS, because of its high metabolic rate and low antioxi-
dant defences at birth (see von Bernhardi et al. 2010).
Furthermore, oxidative stress implies DNA damage, and
activation of sentinel proteins for protecting the genome.
PARP-1 is in the front of sentinel proteins involved in
the maintenance of chromatin integrity, recruiting the DNA
repair machine through poly-ADP ribosylation of histones,
relaxing the chromatin and modulating factors with high
affinity for pADPr, therefore demanding and exhausting
NAD? sources, worsening the energy crisis (Berger 1985),
leading to caspase-independent apoptosis, via translocation
of mitochondrial pro-apoptotic proteins (Jiang et al. 1996;
Yu et al. 2002). Thus, it has been proposed that PARP-1 is
involved in the long-term effects produced by PA (Martin
et al. 2005; Klawitter et al. 2006; see Herrera-Marschitz
et al. 2011), making relevant to monitor PARP-1 levels and
PARP-1 activity at early stages, when the babies are
recovering from PA.
PARP-1 levels were measured in mesencephalon,
immediately after asphyxia, or 1–24 h after delivery,
obtaining rather variable results without a revealing pattern
associated to PA. However, when PARP-1 activity was
estimated by the ratio of pADPr/PARP-1 levels, it was
evident that the insult produced a significant increase of
PARP-1 activity in mesencephalon 1–8 h after PA.
Several studies have pointed out the role of PARP-1
during inflammatory processes, because PARP-1 positively
regulates NFjB activation via (i) IKKc, the kinase that
phosphorylates IjBa, inducing its degradation; (ii) pro-
duction of transcriptionally active subunits of the NFjB
complexes, mainly the dimer p50/RelA (p65) and/or (iii)
via pADP ribosylation of p65, which is translocated to and
retained into the nucleus (Chiarugi and Moskowitz 2003;
see Rosado et al. 2013). Thus, it was found here that IjBa
levels were decreased in the cytosol compartment of
mesencephalic cells 8 h after PA, compared to that
observed in caesarean-delivered control siblings. Further-
more, p65 was translocated to the nucleus, increasing 1 h,
but decreased 8 h after PA.
We further investigated whether p65 translocation led to
de novo synthesis of the pro-inflammatory signalling, IL-
1b and TNFa, monitored along the same experimental
Fig. 4 Effect of nicotinamide or saline on PARP-1 activity in
mesencephalon of asphyxia-exposed and control rats. Caesarean-
delivered control (CS) and asphyxia-exposed (AS) rats were treated
1 h after birth with a single dose of Nam (0.8 mmol/kg, i.p.) (CNam,
ANam) or saline (0.1 ml, i.p.) (CSal, ASal), and euthanized 2 h after
delivery. Brain tissue sampled and treated for Western blots. pADPr
and PARP-1 protein levels were measured in total protein extracts.
PARP-1 activity was estimated as the pADPr/PARP-1 ratio.
a Representative immunoblots for pADPr, PARP-1 and b-actin
levels; b pADPr levels (expressed as arbitrary units, A.U.); c PARP-1
levels (normalized to b-actin, A.U.); d PARP-1 activity (pADPr/
PARP-1 ratio) (CSal open columns, CNam dashed columns, ASal
grey columns, ANam double dashed columns). Pair-wise comparisons
analysed with Student t test (*p \ 0.05, **p \ 0.005, ***p \ 0.0005;
n = 4–5, for each condition and experiment)
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conditions with RT-qPCR and ELISA. It was found that
IL-1b and TNFa mRNA protein levels were increased 24 h
after the insult.
PARP-1 overactivation has been considered to be an
endpoint for several metabolic insults including PA, lead-
ing to the hypothesis that PARP-1 inhibition constitutes a
pharmacological target for preventing the long-term effects
elicited by asphyctic/ischemic insults (see Kauppinen and
Swanson 2007). Thus, we tested here the effect of the
PARP-1 inhibitor nicotinamide, the amide form of nico-
tinic acid (vitamin B3/niacin), on cell death evaluated 24 h
after PA and on PARP-1 activity and the inflammatory
cascade initiated by p65 nuclear translocation at the 2–24 h
period after birth. Nicotinamide interacts with the binding
site for the nicotinamide moiety of NAD? at the active site
of PARP, inducing end product enzymatic inhibition (see
Virag and Szabo 2002). Nicotinamide or saline was
administered 1 h post delivery to PA and control pups. It
was found that nicotinamide significantly decreased cell
death induced by PA, evaluated 24 h after birth.
Delay in starting pulmonary ventilation at birth implies
decrease of oxygen saturation in blood and oxygen supply
to the brain. In response to energy deficit, blood flow is
redistributed to the heart, brain and adrenal glands to
Fig. 5 Effect of nicotinamide or saline on p65 translocation; on p65,
IL-1b and TNF-a mRNA levels, and on ELISA TNF-a protein levels
in mesencephalon of asphyxia-exposed and control rats. Caesarean-
delivered control (CS) and asphyxia-exposed (AS) rats were treated
with a single dose of nicotinamide (0.8 mmol/kg, i.p.) (CNam,
ANam) or saline (0.1 ml, i.p.) (CSal, ASal), 1 h after delivery,
euthanized at 8 or 24 h after birth. Selected brain tissue was treated
for Western blots, RT-qPCR or ELISA. a Representative immuno-
blots for p65, a-tubulin and histone H4 levels, measured in
cytoplasmic (c) and nuclear (n) protein extracts. b Nuclear p65
levels normalized to total p65. c De novo synthesis of p65, d IL-1b
and e TNF-a, measured by RT-qPCR 8 h and/or 24 h after delivery
(data analysed in triplicates with MxPro software, normalized to
GAPDH mRNA levels). f TNF-a protein levels measured in total
protein extracts with Quantikine ELISA Rat (normalized by mg of
protein for each sample, in duplicate) (CSal open columns, CNam
dashed columns, ASal grey columns, ANam doubled dashed
columns). Pair-wise comparisons analysed with Student t test
(*p \ 0.05, **p \ 0.005)
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ensure oxygen supply to these vital organs. This redis-
tribution occurs at the expense of reduced perfusio´n of
kidneys, gastrointestinal tract, muscles, skeleton and skin
(Peeters et al. 1979; Lubec et al. 1997; see Jensen and
Berger 1991; Berger and Garnier 2000). In the brain,
there is also a redistribution of blood flow, favouring the
brain stem at the expense of the cortex (Lou et al. 1985),
and probably, further re-compartmentalisation occurs
depending upon the developmental stage of particular
regions (see Herrera-Marschitz et al. 2011, 2014). During
re-oxygenation, extracellular levels of glutamate are
increased, enhancing the activation of Na?/K? ATPase,
increasing further ATP consumption. Extracellular gluta-
mate levels overpass the buffer capacity of astrocytes,
resulting in overactivation of glutamate receptors, mainly
of the N-methyl-D-aspartate (NMDA) subtype, increasing
Ca2? conductance and further improper homeostasis,
therefore, glutamate antagonism has been proposed as a
therapeutic intervention, with rather mild effects (see
Engidawork et al. 2001). The metabolic crisis is probably
sustained by over expression of alternative metabolic
pathways, prolonging the energy deficit and oxidative
stress, leading to cell death, which can occur via several
mechanisms. The prevalent type of delayed cell death in
the perinatal brain is apoptosis, which is mediated by
caspase-dependent and caspase-independent mechanisms
(Northington et al. 2001; see Morales et al. 2008). Indeed,
not only pro-apoptotic proteins have been observed to be
increased following PA, including Bcl-2 associated X
(BAX), and Bcl-2 associated death (BAD) factors, but
also anti-apoptotic proteins, including Bcl-2, ERK2 and
bFGF, suggesting the activation of neuroprotective and
repair pathways (Morales et al. 2005, 2008). Extensive
and regionally selective nuclear fragmentation has been
observed in control and asphyctic rat pups, depending
upon the stage of development and the analysed brain
region (Dell’Anna et al. 1997). In the present report, we
focused on a short period, 24 h, in order to pick up
metabolic events leading to an early relevant endpoint,
finding increased apoptotic-like cell death in mesenceph-
alon, both in SN and VTA. Also hippocampus and tel-
encephalon have been shown to be relevant targets, but
only when assayed 1 week or longer periods after birth
(Dell’Anna et al. 1997; Morales et al. 2010).
Several assays have been developed to measure PARP-1
enzymatic activity (see Allende-Castro et al. 2012). We
chose here an in vivo assay based on pADPr accumulation,
estimating the ratio between pADPr and PARP-1 levels
(ratio end product/enzyme level), revealing an early,
regionally specific profile, indicating that PARP-1 activity
is indeed increased by PA, further demonstrated by the
effect of nicotinamide, reversing the overactivation of
PARP-1 2 h after birth.
Several studies have suggested further that PARP-1
inhibition protects against acute and chronic inflammation,
since PARP-1 positively regulates NFjB activation, via
IKKc, the kinase phosphorylating IjBa, inducing its deg-
radation, also favouring pADPribosylation of the p50/p65
dimer and its ulterior translocation (see Rosado et al. 2013;
also Zerfaoui et al. 2010). We measured here IjBa, and
p65 levels in cytoplasma and nuclear protein fractions, and
transcription of pro-inflammatory signals, finding that IL-
1b and TNF-a mRNA levels were increased in mesen-
cephalon of asphyxia-exposed animals, together with a
decrease of IjBa levels and p65 nuclear translocation,
effects that were prevented by nicotinamide, mainly on
TNF-a, at mRNA and protein levels, monitored with RT-
qPCR and ELISA, respectively. The NFjB cascade leads
to IL-1b and TNF-a transcription and other inflammatory
genes, such as IL-6. IL-1b is synthesized as a pro-IL-1b,
which has to be cleavaged to generate mature IL-1b. In the
present study, no effect was observed on IL-1b protein
levels, perhaps because IL-1b maturation implies activa-
tion of caspase-1 and a multiprotein cytoplasmatic complex
named inflammasomes, associated to neurotoxicity (see
Schroder and Tschopp 2010). TNF-a was monitored at
both mRNA and protein levels, revealing a significant
increase in mesencephalon of asphyxia-exposed animals
24 h after the insult, prevented by nicotinamide. A similar
effect has been observed in hippocampus, also prevented
by nicotinamide, but mainly 8 h after the insult (Neira-
Pena et al. in preparation), suggesting the involvement of
different protein cascades (see Palladino et al. 2003).
Interestingly, exposure of embryonic rat mesencephalic
neuronal cultures to TNF-a resulted in a dose-dependent
decrease of the number of tyrosine hydroxylase (TH)
immunoreactive cells (see Kraft and Harry 2011). In
humans, a relationship between IL-1b, IL-6 and TNF-a
serum level and the outcome of PA suffering infants has
been established. Infants deceased before the first year of
life, or diagnosed as suffering of cerebral palsy, presented
elevated levels of pro-inflammatory cytokines, compared to
that shown by infants with a normal outcome (Foster-
Barber et al. 2001), suggesting that pro-inflammatory
cytokine levels provide a predictive value for the final
neurological outcome (Aly et al. 2006).
Conclusions
PA leads to death whenever re-oxygenation is not promptly
re-established. In rats, it leads to a significant decrease of the
survival rate. We show here that surviving pups show an
increase of TUNEL-positive cell death evaluated 24 h after
birth. Cell death implies DNA damage, and activation of
sentinel genome protecting proteins. PARP-1 is in the front
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of sentinel proteins involved in the maintenance of chro-
matin integrity, demanding and exhausting available NAD?
pools, worsening the energy crisis. PARP-1 activity was
monitored at early stages after birth, in a brain region
showing increased cell death. When estimating PARP-1
activity by the ratio of pADPr/PARP-1 levels, it was evident
that the insult led a significant increase of PARP-1 activity in
mesencephalon. The increase of PARP-1 activity was asso-
ciated to p65 translocation and de novo synthesis of pro-
inflammatory signalling, IL-1b and TNFa. Nicotinamide
prevented PA-induced PARP-1 overactivity, p65 transloca-
tion, and reversed the increase of inflammatory signalling,
mainly TNF-a. Thus, the present results show that PA leads
to overactivation of PARP-1, increasing the expression of
pro-inflammatory cytokines and cell death, effects prevented
by systemic neonatal nicotinamide administration.
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